News | May 29, 2023
Wockhardt’s Q4 FY23 three fold jump in EBITDA over Q4 FY22
Two patents were filed during the quarter ended 31st March, 2023 and the cumulative filings till date are 3239
Two patents were filed during the quarter ended 31st March, 2023 and the cumulative filings till date are 3239
New facility is based at Lonza’s Bend, Oregon (US) site, a Center of Excellence for bioavailability enhancement
South Asia’s largest exhibition for pharma brought together over 50,000 visitors from across the globe
This is the fifth consecutive year that a Biocon Group company has made it to the Asia lP ELITE list
Complaints to be filed in both United States and Germany alleging that Pfizer and BioNTech's COVID-19 vaccine Comirnaty unlawfully infringes patents Moderna filed between 2010 and 2016
The Trial, the first of its kind in Israel, recently obtained approval from the Israeli Ministry of Health and is preparing for participant recruitment.
All claims made by Seagen regarding Daiichi Sankyo antibody drug conjugates are denied
He has over 25+ years of experience in the pharmaceutical Industry and has been working with the company for the past 6 years
Driven by a strong commitment to better serve its global customers in medical and consumer products, this investment represents the largest capacity expansion in Cariflex’s existing accomplishments
Advancing to IND-enabling studies with multiple drug candidates
Subscribe To Our Newsletter & Stay Updated
